Clinical Treatment of the Elderly: Never Too Late

1987 ◽  
Vol 32 (12) ◽  
pp. 1036-1036
Author(s):  
Susan Krauss Whitbourne
Aging ◽  
2020 ◽  
Vol 12 (9) ◽  
pp. 7619-7625 ◽  
Author(s):  
Jing Liu ◽  
Bobin Mi ◽  
Liangcong Hu ◽  
Yuan Xiong ◽  
Hang Xue ◽  
...  

2021 ◽  
Vol 5 (4) ◽  
pp. 103-105
Author(s):  
Sen Li ◽  
Zhenxing Qu ◽  
Hua Zhang ◽  
Zhibin Li

Osteoporosis is a systemic chronic metabolic bone disease, mainly in the elderly and postmenopausal women. At present, most of the clinical treatment is western medicine, but the curative effect is not very significant. In the treatment of osteoporosis, traditional Chinese medicine (TCM) is mainly based on the overall concept of TCM. This article briefly analyzes osteoporosis from the theory of “liver and kidney homology,” discusses the research on osteoporosis in TCM, and hopes to provide reference for the clinical treatment and research of osteoporosis.


2019 ◽  
Vol 5 (2) ◽  
Author(s):  
Ryan B. Thomas ◽  
Se Ryeong Jang ◽  
Marco Lombardi ◽  
Vittorio Maio

Appropriate prescribing in the elderly can be challenging. While most of the older patients suffer from multiple comorbidities and undergo physiological changes with aging, no clinical guidelines account for these unique characteristics of the elderly adequately. Our commentary proposes a continuous process of prescribing and deprescribing as a necessary step for providers to prevent adverse drug events associated with unnecessary polypharmacy, a result of clinical guidelines working in silos. In addressing this issue, we employed Dr. Nick Barber’s four tenants of appropriate prescribing – maximize effectiveness, minimize risk, minimize cost, and respect patient choice – as a framework to guide providers through actionable insights on how to optimize the intended effects of their clinical treatment while also achieving desirable humanistic and economic outcomes.


Author(s):  
J. Jacob ◽  
M.F.M. Ismail

Ultrastructural changes have been shown to occur in the urinary bladder epithelium (urothelium) during the life span of humans. With increasing age, the luminal surface becomes more flexible and develops simple microvilli-like processes. Furthermore, the specialised asymmetric structure of the luminal plasma membrane is relatively more prominent in the young than in the elderly. The nature of the changes at the luminal surface is now explored by lectin-mediated adsorption visualised by scanning electron microscopy (SEM).Samples of young adult (21-31 y old) and elderly (58-82 y old) urothelia were fixed in buffered 2% glutaraldehyde for 10 m and washed with phosphate buffered saline (PBS) containing Ca++ and Mg++ at room temperature. They were incubated overnight at 4°C in 0.1 M ammonium chloride in PBS to block any remaining aldehyde groups. The samples were then allowed to stand in PBS at 37°C for 2 h before incubation at 37°C for 30 m with lectins. The lectins used were concanavalin A (Con A), wheat germ agglutinin (WGA), phytohaemagglutinin (PHA) and pokeweed mitogen (PWM) at a concentration of 500 mg/ml in PBS at pH 7.A.


1988 ◽  
Vol 52 (9) ◽  
pp. 516-518 ◽  
Author(s):  
J Mann ◽  
TJ Bomberg ◽  
JM Holtzman ◽  
DB Berkey
Keyword(s):  

Author(s):  
Angel L. Ball ◽  
Adina S. Gray

Pharmacological intervention for depressive symptoms in institutionalized elderly is higher than the population average. Among the patients on such medications are those with a puzzling mix of symptoms, diagnosed as “dementia syndrome of depression,” formerly termed “pseudodementia”. Cognitive-communicative changes, potentially due to medications, complicate the diagnosis even further. This discussion paper reviews the history of the terminology of “pseudodementia,” and examines the pharmacology given as treatment for depressive symptoms in the elderly population that can affect cognition and communication. Clinicians can reduce the risk of misdiagnosis or inappropriate treatment by having an awareness of potential side effects, including decreased attention, memory, and reasoning capacities, particularly due to some anticholinergic medications. A team approach to care should include a cohesive effort directed at caution against over-medication, informed management of polypharmacology, enhancement of environmental/communication supports and quality of life, and recognizing the typical nature of some depressive signs in elderly institutionalized individuals.


Sign in / Sign up

Export Citation Format

Share Document